Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christophe Caux

Showing results (111-120 of 142) with videos related to

Pageof 15
Sort By:
American Journal of Hematology|June 27, 2022
HERVs characterize normal and leukemia stem cells and represent a source of shared epitopes for cancer immunotherapyVincent Alcazer, Paola Bonaventura, Laurie Tonon, et al.
Cancer Research|June 24, 2011
Quantitative and functional alterations of plasmacytoid dendritic cells contribute to immune tolerance in ovarian cancerSana Intidhar Labidi-Galy, Vanja Sisirak, Pierre Meeus, et al.
Journal for Immunotherapy of Cancer|June 18, 2026
Melanoma cell states shape spatial tumor-immune ecosystems to dictate the efficacy of anti-PD1 immunotherapyFélix K Pham, Marion Dufeu, Valentin Benboubker, et al.
Journal for Immunotherapy of Cancer|March 15, 2022
ZEB1 transcription factor promotes immune escape in melanomaMaud Plaschka, Valentin Benboubker, Maxime Grimont, et al.
Cancer Research|February 27, 2009
Regulatory T cells recruited through CCL22/CCR4 are selectively activated in lymphoid infiltrates surrounding primary breast tumors and lead to an adverse clinical outcomeMichael Gobert, Isabelle Treilleux, Nathalie Bendriss-Vermare, et al.
Breast Cancer (Dove Medical Press)|May 4, 2023
Pembrolizumab in Lymphopenic Metastatic Breast Cancer Patients Treated with Metronomic Cyclophosphamide: A Clinical and Translational Prospective StudyBenoîte Mery, Christine Ménétrier-Caux, Laure Montané, et al.
Journal of Leukocyte Biology|August 6, 2005
Virus overrides the propensity of human CD40L-activated plasmacytoid dendritic cells to produce Th2 mediators through synergistic induction of IFN-{gamma} and Th1 chemokine productionNathalie Bendriss-Vermare, Stéphanie Burg, Holger Kanzler, et al.
Acta Neuropathologica|January 5, 2018
Genetic alterations and tumor immune attack in Yo paraneoplastic cerebellar degenerationMathilde Small, Isabelle Treilleux, Coline Couillault, et al.
Clinical & Translational Immunology|February 22, 2020
CD163<sup>+</sup> tumor-associated macrophage accumulation in breast cancer patients reflects both local differentiation signals and systemic skewing of monocytesRodrigo Nalio Ramos, Céline Rodriguez, Margaux Hubert, et al.
Oncoimmunology|December 8, 2018
Immunological and classical subtypes of oral premalignant lesionsJean-Philippe Foy, Chloé Bertolus, Sandra Ortiz-Cuaran, et al.
Pageof 15

Showing results (111-120 of 142) with videos related to

Sort By:
Pageof 15
American Journal of Hematology|June 27, 2022
HERVs characterize normal and leukemia stem cells and represent a source of shared epitopes for cancer immunotherapyVincent Alcazer, Paola Bonaventura, Laurie Tonon, et al.
Cancer Research|June 24, 2011
Quantitative and functional alterations of plasmacytoid dendritic cells contribute to immune tolerance in ovarian cancerSana Intidhar Labidi-Galy, Vanja Sisirak, Pierre Meeus, et al.
Journal for Immunotherapy of Cancer|June 18, 2026
Melanoma cell states shape spatial tumor-immune ecosystems to dictate the efficacy of anti-PD1 immunotherapyFélix K Pham, Marion Dufeu, Valentin Benboubker, et al.
Journal for Immunotherapy of Cancer|March 15, 2022
ZEB1 transcription factor promotes immune escape in melanomaMaud Plaschka, Valentin Benboubker, Maxime Grimont, et al.
Cancer Research|February 27, 2009
Regulatory T cells recruited through CCL22/CCR4 are selectively activated in lymphoid infiltrates surrounding primary breast tumors and lead to an adverse clinical outcomeMichael Gobert, Isabelle Treilleux, Nathalie Bendriss-Vermare, et al.
Breast Cancer (Dove Medical Press)|May 4, 2023
Pembrolizumab in Lymphopenic Metastatic Breast Cancer Patients Treated with Metronomic Cyclophosphamide: A Clinical and Translational Prospective StudyBenoîte Mery, Christine Ménétrier-Caux, Laure Montané, et al.
Journal of Leukocyte Biology|August 6, 2005
Virus overrides the propensity of human CD40L-activated plasmacytoid dendritic cells to produce Th2 mediators through synergistic induction of IFN-{gamma} and Th1 chemokine productionNathalie Bendriss-Vermare, Stéphanie Burg, Holger Kanzler, et al.
Acta Neuropathologica|January 5, 2018
Genetic alterations and tumor immune attack in Yo paraneoplastic cerebellar degenerationMathilde Small, Isabelle Treilleux, Coline Couillault, et al.
Clinical & Translational Immunology|February 22, 2020
CD163<sup>+</sup> tumor-associated macrophage accumulation in breast cancer patients reflects both local differentiation signals and systemic skewing of monocytesRodrigo Nalio Ramos, Céline Rodriguez, Margaux Hubert, et al.
Oncoimmunology|December 8, 2018
Immunological and classical subtypes of oral premalignant lesionsJean-Philippe Foy, Chloé Bertolus, Sandra Ortiz-Cuaran, et al.
Pageof 15